Schedule 13D ownership disclosure
ACHILLION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00448Q201
Event date: 2014-06-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 22,486,007
- Percent of class
- 23.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-14-039304
- Form type
- SC 13D
- Filer
- ACHILLION PHARMACEUTICALS INC
- CIK
- CIK 1070336
- Filed
- Jun 24, 2014
- Reporting period
- Jun 20, 2014
- Description
- Schedule 13D beneficial ownership